Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast Cancer

Clinical trial NCT07771881 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07771881
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Thrombocytopenia Chemotherapy Induced

Start date: 2026-08-01
Primary completion: 2028-04-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.